|
11. |
The Increase in Growth Hormone Secretion in Experimentally Induced Arthritic Rats Is an Adaptive Process Involved in the Regulation of Inflammation |
|
Neuroendocrinology,
Volume 63,
Issue 1,
1996,
Page 85-92
Marie-Thérèse Bluet-Pajot,
Françoise Mounier,
Annie Slama,
Catherine Videau,
Claude Kordon,
Jacques Epelbaum,
Bernard Calvino,
Preview
|
PDF (1543KB)
|
|
摘要:
In Sprague-Dawley rats, Freund-adjuvant-induced arthritis (AIA) results in an increase in the amplitude of ultradian growth-hormone (GH)-secretory episodes without modification of their frequency. This is most apparent at the time of maximal inflammation, i.e. 14–21 days after inoculation of the adjuvant. GH responsiveness to a maximal dose of clonidine (10 µg/100 g body weight, BW), a secretagogue known to act at the hypothalamic level, is comparable in AIA and control rats. In contrast, GH response to a maximal dose of GH-releasing hormone (GHRH, 1 µg/100 g BW), a peptide acting directly on pituitary somatotropes, is greater in AIA than in control rats. Furthermore AIA affects significantly neither hypothalamic somatostatin and GHRH mRNA levels nor pituitary GH content. In adult rats treated neonatally with monosodium glutamate (MSG), a neurotoxin which destroys the majority of GHRH neurons of the arcuate nucleus and reduces considerably plasma GH levels, clinical symptoms observed 14 days after inoculation of the Freund adjuvant are more marked than in AIA. The MSG-treated rats exhibit in particular a significantly higher increase in hindpaw diameter. Pulsatile administration of GH (40 µg/day/rat, with successive periods of 2 h of GH and 4 h of mineral oil) restoring the endogenous GH-secretory pattern throughout the 15-day period of arthritis development prevents hindpaw diameter increase. These results indicate that the impact of AIA on GH regulation occurs at the pituitary but not the hypothalamic level and suggest that increased GH secretion observed in AIA rats is an adaptive mechanism involved in the regulation of the inflammatory pro
ISSN:0028-3835
DOI:10.1159/000126939
出版商:S. Karger AG
年代:1996
数据来源: Karger
|
12. |
Differential Neuroendocrine and Behavioral Responses to Cocaine in Lewis and Fischer Rats |
|
Neuroendocrinology,
Volume 63,
Issue 1,
1996,
Page 93-100
Renée Simar,
David Saphier,
Nick E. Goeders,
Preview
|
PDF (1613KB)
|
|
摘要:
Lewis (LEW) and Fischer 344 (F344) rats differ in responsiveness of the hypothalamo-pituitary-adrenocortical (HPA) axis as well as in their behavioral responses to drugs of abuse. The present experiments were conducted to compare hypothalamic corticotropin-releasing factor (CRF), plasma adrenocorti-cotropic hormone (ACTH) and plasma corticosterone (CS) responses to cocaine (0–60 mg/kg, i.p.) in LEW and F344 rats. Acute administration of cocaine resulted in decreases in CRF and dose-related increases in CS and ACTH with significant differences observed between the strains. Cocaine also increased plasma norepinephrine concentrations. Although the CS response was increased in the F344 compared to LEW rats, the percent change in the CS response was markedly enhanced in LEW rats. Plasma ACTH concentrations as well as the percentage of the control response were dramatically increased at the 40 mg/kg cocaine dose in the LEW compared to F344 rats. Since cocaine-induced changes in HPA axis activity may contribute to behavioral responses to cocaine, another experiment was performed to compare the locomotor responses to novelty and to acute cocaine between LEW and F344 rats. Strain differences were not observed in the locomotor response to novelty or to cocaine. These data indicate that strain differences exist in the neuroendocrine response to acute cocaine exposur
ISSN:0028-3835
DOI:10.1159/000126940
出版商:S. Karger AG
年代:1996
数据来源: Karger
|
|